K. Wisemandle

Statistics

Publications

Citations

624

H-Index

Active since

2005

Affiliations

Astellas Pharma (United States)(Current)

Tulane University

University of Minnesota

Medical College of Wisconsin

University of Miami

K. Wisemandle is an author at Astellas Pharma (United States) specializing in transplant pharmacokinetics, tacrolimus therapy, and tacrolimus pharmacokinetics.

Publications per year

2005–2007

Publications

One-Year Results with Extended-Release Tacrolimus/MMF, Tacrolimus/MMF and Cyclosporine/MMF in De Novo Kidney Transplant Recipients

H lio Tedesco Silva, H C Yang, Marwan Abouljoud et al. · American Journal of Transplantation · 2007 · 177 citations

Medicine, Immunology, Nephrology +16

Conversion of Stable Kidney Transplant Recipients From a Twice Daily Prograf-Based Regimen to a Once Daily Modified Release Tacrolimus-Based Regimen

Rita R. Alloway, S. Steinberg, Khalid Khalil et al. · Transplantation Proceedings · 2005 · 161 citations

Medicine, Nephrology, Pharmacotherapy +16

Conversion of Stable Liver Transplant Recipients From a Twice-Daily Prograf-Based Regimen to a Once-Daily Modified Release Tacrolimus-Based Regimen

Sander Florman, Rita R. Alloway, Münci Kalayoğlu et al. · Transplantation Proceedings · 2005 · 93 citations

Pharmacy, Pharmacotherapy, Transplant Immunology +14

Two Years Postconversion From a Prograf-Based Regimen to a Once-Daily Tacrolimus Extended-Release Formulation in Stable Kidney Transplant Recipients

Rita R. Alloway, Steven Steinberg, Kassem Khalil et al. · Transplantation · 2007 · 80 citations

Medicine, Nephrology, Pharmacotherapy +17

Once-Daily Tacrolimus Extended-Release Formulation: 1-Year Post-Conversion in Stable Pediatric Liver Transplant Recipients

T.G Heffron, Mark D. Pescovitz, Sander Florman et al. · American Journal of Transplantation · 2007 · 60 citations

Pharmacy, Pediatrics, Pharmacokinetics +16

1–5 of 6